respiratory
Asthma

Evidence does not support LABA as an adjunct in children


Adding a LABA to ICS treatment in school-aged children with persistent asthma does not reduce the risk of exacerbations requiring steroid treatment, a Cochrane review confirms. The review of 33 studies found that stepping up therapy with the addition of LABA to the usual dose of ICS improved lung function beyond that observed when remaining ...

Already a member?

Enter your email to keep reading.


OR